Hedge Fund - Scopia Capital

According to a recently-amended 13D filing with the SEC, Gregory A. Boland’s West Face Capital disclosed an ownership stake of 4.17 million shares in SunOpta Inc.

A newly amended 13G filing with the SEC reveals that Matt Sirovich and Jeremy Mindich’s Scopia Capital currently owns 1.88 million shares in Mellanox Technologies Ltd.

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.

As we continue to track hedge funds’ SEC filings, we came across a few interesting transactions, into which we will look in this article.

Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals, Inc.

Matt Sirovich and Jeremy Mindich's Scopia Capital has sliced its exposure to G-III Apparel Group, Ltd. (NASDAQ:GIII) to some 970,300 shares, from about 1.1 million shares revealed in the latest 13F.

At the moment, there are plenty of metrics market participants can use to track stocks. A duo of the best are hedge fund and insider trading activity.

To the average investor, there are dozens of metrics market participants can use to track stocks. A couple of the most underrated are hedge fund and insider trading interest.

Now, according to many market players, hedge funds are assumed to be bloated, old investment tools of a period lost to current times.